Editorials |
From the Department of Medicine, Rheumatology Section, VA Health Care System/UCSD, San Diego, Calif.
Correspondence to Robert Terkeltaub, MD, VA Medical Center, Rheumatology, 3350 La Jolla Village Drive, San Diego, CA 92161. E-mail rterkeltaub@ucsd.edu
Key Words: arterial calcification RANKL osteoprotegerin BMP2 smooth muscle cell
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
See accompanying article on page 2158
In a study published in the current issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Preusch et al report the effects of lineage-specific deletion of the glucocorticoid receptor (GR) in bone marrow-donor macrophages on chondro-osseous differentiation and calcification in dietary-induced atherosclerotic lesions in lethally irradiated, bone marrow transplant recipient, LDLR knockout mice.6 Arterial calcification appears to be an active and organized multicellular process, which is switched on by chondro-osseous differentiation of a variety of progenitors in the artery wall, and regulated in part by systemic influences. Such influences include the effects of calciotropic hormones and of mineral nucleation promoters and inhibitors.1–4 In the intralesional intercellular dialogue that drives vascular calcification, potential progenitors of calcifying osteoblastic and chondrocytic cells include not only pericytes and resident and recruited vascular stem cells, but also nonterminally differentiated phenotypically plastic adventitial myofibroblasts
Related Article:
Arterioscler Thromb Vasc Biol 2008 28: 2158-2164.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |